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Wehaveevaluatedthis relationshipusingB-modecarotidultraeonography.
IMTandcrosssectionalsystolicdiametarof the rightCCAweremeasured
in 290volunteers(M: 157,63.6+ 15.6,26-95, F: 133,56.2+ 16.0,26-90)
fromthe BaltimoreLongitudinalStudyof Aging.Basedon medicalhistory,
restingECGandmaximaltreadmillexerciseECG,aubjectawereclassified
Into3 groups:G-O:withnoclinicalor resf/exerciseECGevidenceof CHD(n
= 220),G-1:possibleCHD(n = 47) definedby asymptomaticiachamicST
segmentdepression> 1.0mmon exerciseECGwithoutclinicalsymptoms
andG-2:manifeatCHD(n= 23).
Ags* % Men SBP (mmHg) Diameter (mm) IMr (mm)
G-o 58& 16 50 120* 14+ 6.1 * 0.7 0.51 *0.14G-1 68+ 14 60 126 +18 6.3 *0.7
G-2
0.66+0.19
78& 7 63** 125 l17 6.34z0.7 0.69 +0.19
(“Allgroupsdifieratp=0.0000,**P c 0.01 and ‘p < 0.05vs othsrtwo groups)
Bycorrelationanalysis,IMTwaspositivelyaa-sociatadwithage(r= 0.63,
P = 0.000),systolicbloodpressure(SBP)(r = 0.27,p = 0.000)and CCA
diameter(r= O.30,P=O.000).Bymultipleregression,IMTwasbaatexplained
by age (p= 0.0000),CCAdiameter(p < 0.001),posaibleCHD(p < 0.01)
and manifestCHD(P = 0.0000)(model# = 0.57).Thus,the presenceof
possibleCHD,asevidencedbyasymptomaticexercise-inducedSTsegment










279women,meanage61 + 8 years.Fortyto 100%ECADoccurredin 22
of 121men(18%)andin43 of 279women(15%)(p= 0.490).Meanplasma
homooysteinelevel (wmolper liter)was 19 + 6 in menwithECADversua
14 + 4 in menwithoutECAD(p = 0.003)and 17+4 in womenwithECAD
veffiue13+ 5 in womenwithoutECAD(p < 0.0001).Meanplasmavitamin
BIZ(n@parliter)wae454+ 215inmenwithECADversus553& 164in men
withoutECAD(p= 0.052)and443+ 126in womenwithECADversus533
A 157in womenwithoutECAD(p = 0.0305).Meanplasmafolatelevel(#g
per liter)was6.3 & 2.1 in menwithECADversue9.5+ 3.2 in manwithout
ECAD(p= 0.0001)and6.3+ 1.4in womenwithECADversus9.5+ 3.1 in
womenwithoutECAD(p = 0.0001).A low plasmafolatelevel(< 3 ~g par
liter)was presentin noneof 400 persons(O%).A lowplasmavitaminB12
level (c 160nglparliter)waspresentin2 of22 men(9%)withECADversus
1 of 99 men (l%) withoutECAD(p = 0.085)and in 1 of 43 women(2%)
with ECADversus1 of 236 women(c IYo) withoutECAD(p = 0.285).An
increasedplasmahomocysteinelevel(> 17wmolpar liter)occurredin 10
of 22 men(L15Yo)withECADversus20 of 99 men(20%)withoutECAD(p=













Todeterminethe influenceof trenspoti(T)on hrx.piteloutcomes,datawere
reviewedfor4367 consecutivepatientsundergoingcoronatyarterybypeea
betwwn l/1/90 and lZ3i/95. Of which,1374patients(32%)weretrans-




Outcome T Non-T p (unadj.) p (adj.)
Mortality(%) 7.2 4.0 <0.001 0,134
Complication(%) 22.6 16.5 <0,001
LOS (d)
0.387
9.s 9.0 <0,001 0.116
Preop LOS (d) 1.4 1,4 <0.001 0.367
ICU LOS (d) 3.4 2,5 <0.001 0.006
PoatopLOS (d) 8.4 7.6 0.001 0.860
Coats ($1,000) 21.7 19,3 <0,001 0.032
Cone/usions:l)Beforeriskadjustment,transpotiedpatientshadmarkedly
worseclinicalandcostoutcomesthannon-transportedpatients.2) Afterriak
adjustment,hospitalcostsand ICUlength-of-stayare still longerfor trans-






The long-termresultsof the modifiedDe Vegatricuspidannuloplasty(TA)
in rheumaticpatientsundergoingleft-sidedvalvereplacementareunknown.
BetweenSeptember1989and December1991,TAwae performedon 49
patients(pts)thatsurvivedsurgetyfor aortic,mitralor doublevalvereplace-
ment.Completeechooardiographicfoliow-upwasavailablein 43 pta(mean
age31 k 13years,meanfollow-up57 + 16 monthe).Atrialfibrillationwee
documentedpreoperetivelyin20/43pta.PreoperativeindicationsforTAwere
moderateor severetricuspidregurgitationin 33 ptsandmildor notricuapid
regurgitationbut a dilatedtricuspidannulua(233 mm) on 2 dimensional
echocsrdiographyat enddiastolein 10pta.Organictticuepidleafletdisease
waadocumentedin 16/43pts. Long-termmortalitywas 12% (6 pts, none
hadmorethan mild residualtricuspidregurgitationat Iateetfoilow-up).On
Dopplercolorflowmapping,postoperativeseveretricuspidregurgitationwee
presentin1ptandmoderatetricuspidregurgitationin4ptsat Iatestfollow-up.
Thetricuspidannulussizedeclinedfrom37 + 5 mmpreoperetivelyto 24 +
6 mmat latestfollow-up(p e 0.0001).Pulmonaryarterysyatolicpressure
declinedfrom53+ 21mmHgatbaselineto39+ 16mmHg(P=O.03)at latest
follow-upin the 16 pts in whompulmonarypressurecouldbe assessedby
Dopplerexaminationpre-andpostoperatively.Inconclusion:1)ModifiedDe












ever, it is unknownhow these2 groupsdiffer on long term follow-up.by
Dopplerechocardiography(2De).Methods:2Dewas uaedto study67 pte
(66.2+ 15.4yrs)whohadMVrepair(n= 46) or replacementwith(n = 17)
or without(n= 24)PSVA.All ptshadpreoperative2De <1 month(M)prior
to surgaryandat follow-up12&9 montha(M)aftersurgery.Results:There
weenoaignificentchangeintheLVEFbetweenthepreopandpoatop2Deat
12+ 9 Mfollow-up.
PAP LVEDD LVESD LAs
pre poatop pra postop pre postop pre poetop
MV repair 43& 9 36+ 13* 55 &7” 51 k 7* 38+ 8 34&8* 49+7 44 *6*
MVR PSV 47 k S 35&6* 55+9 46 =t7* 33 k6 33& 9* 52 k 4 47*8*
MVR only 41 + 9 39+10 53+6 51 + 6 35*7 33* 7 52& 9 49+ S
*p< 0.01, PAP: pulmona~artery preaeure, EDD: end diastolicdimenaion,ES: end eye-
tolio,LAS: Iettatrlalsize.
Cone/uaions.’At 12 + 9 M ptswho hadPSVA,regardlessof havingMV
repairor replacement,hadimprovementin LVEDD,LVESD,IAS and PAP
(p < 0.01)whereasno improvementin theseparameterswasfoundin pts
whodid not havepreservationof the mitralsubvalvularapparatus,despite
comparableejectionfractionspre-opandpost-opin all thegroups.
